Mithra Pharmaceuticals

October 08, 2020

Mapping the transatlantic divide for biotech flotations

A look at how drug developers fare after floating in Europe suggests why many tread a path to the US and a Nasdaq listing.

Mid and small caps provide another rocky ride in the second quarter

Clinical progress – or the lack of it – underpins smaller biotechs' Q2 stock performance.

April 05, 2018

Small and mid-cap share price gains make up for majors

Deals were a major driver of mid-cap share movement in the first quarter, but pipeline progress and misfires played their parts too.